KRT5 and papilloma: In the second study, LSL-K-rasG12D; K5.Cre*PR1 mice dosed with RU486 in the oral cavity (to induce K-rasG12D expression under the control of the K5 promoter) developed exophytic papillomas of the oral mucosa, tongue, and palate 16–24 weeks after exposure 15.